Study on Herpes Zoster Reactivation Induced by Arsenic in Patients with Acute Promyelocytic Leukemia.
10.19746/j.cnki.issn.1009-2137.2022.01.012
- Author:
Chen-Yang ZHAO
1
;
Xin-Xin ZHANG
1
;
Sha GONG
1
;
Shu CHEN
1
;
Xiao-Juan ZHANG
1
;
Su-Hua WEI
1
;
Huai-Yu WANG
2
Author Information
1. Department of Hematology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shaanxi Province, China.
2. Department of Hematology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shaanxi Province, China,E-mail: whymed@126.com.
- Publication Type:Journal Article
- Keywords:
acute promyelocytic leukemia;
arsenic;
herpes zoster
- MeSH:
Arsenic;
Herpes Zoster/epidemiology*;
Herpesvirus 3, Human;
Humans;
Leukemia, Promyelocytic, Acute/drug therapy*;
Retrospective Studies
- From:
Journal of Experimental Hematology
2022;30(1):72-76
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate herpes zoster reactivation induced by arsenic in patients with acute promyelocytic leukemia (APL).
METHODS:The clinical data of 212 patients with APL treated in the Department of Hematology of the First Affiliated Hospital of Xi'an Jiaotong University from 2008 to 2019 were retrospectively analyzed to observe the activation of varicella zoster virus induced by arsenic. Kaplan-Meier analysis, chi-square test, and boxplot were used to analyze and describe the cumulative dose of arsenic and the time from the beginning of arsenic treatment to the occurrence of herpes zoster.
RESULTS:Excluding early death cases and early automatic discharge cases, 17 cases developed herpes zoster reactivation in 175 patients with APL treated with arsenic, and the cumulative median dose of arsenic was 6.2(2-12) mg/kg. Precise risk of reactivation of herpes zoster with 10 months in APL patients treated by arsenic was 9.7%.
CONCLUSION:Arsenic treatment can induce high reactivation rate of herpes zoster virus.
